Immunoseq Trademark Details

Immunoseq was registered on Tuesday, May 7, 2013 and is currently owned by Adaptive Biotechnologies Corporation under the registration number 4330339 . This mark is alive with a status of Registered. The last case file activity for this mark occured 11 years ago on Tuesday, May 7, 2013, according to the United State Patent & Trademark Office
Word Mark Immunoseq
Status Alive Registered 700 — Registered

Current Owner

Adaptive Biotechnologies Corporation of Seattle, WA

View all trademarks for Adaptive Biotechnologies Corporation
Other Trademarks for Adaptive Biotechnologies Corporation
Serial Number 85545319
Registration Number 4330339
Status Date Tuesday, May 7, 2013
Filing Date Tuesday, May 7, 2013
Registration Date Tuesday, May 7, 2013
Attorney Hoang-chi Truong

Correspondent

Hoang-chi Truong
Patent Law Works LLP
201 S. Main Street, Suite 250
Salt Lake City UT 84111

Case File Statements

Amendment to a Registration/Renewal Certificate The drawing is amended to appear as follows: PUBLISH NEW CUT. In the statement, lines 22 through 26 are deleted, and "The mark consists of the word "immunoSEQ" with the wording "immuno" in lower case, the wording "SEQ" in uppercase, and the "Q" in "SEQ" appears as a magnifying glass with a glint/reflection mark inside the "Q"" is inserted.
Description of Mark The mark consists of the word "immunoSEQ" with the wording "immuno" in lower case, the wording "SEQ" in uppercase, and the "Q" in "SEQ" appears as a magnifying glass with a glint/reflection mark inside the "Q".
Goods & Services Development of new technology for others in the field of biotechnology; DNA analysis services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of genetics and genetic engineering
Pseudo Mark Immuno Seq

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, February 24, 2012
First Use Anywhere Tuesday, September 8, 2009
First Use In Commerce Tuesday, September 8, 2009
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.